Industry experts state that orphan drugs will be a major trend to watch in the years ahead, accounting for almost 40% of the Food and Drug Administration approvals this year. This market has become more competitive in the past few years, increasing the potential for reduced costs and broader patient accessibility. Currently, these products are often expensive because they target specific conditions and cost on average $147,000 or more per year, making commercialization
Read More
Personalized Medicine | Digital Health | News, Analysis, Insights - HIT Consultant
NIH Taps PhysIQ to Develop AI-Based COVID-19 Digital Biomarker
What You Should Know:
- physIQ has been selected by the National Institute of Health (NIH) to develop an innovative AI-based COVID-19 digital biomarker solution to address the COVID-19 pandemic.
- Early detection of COVID-19 decompensation in patients
is complicated by infrequent and non-specific clinical data. The first-in-kind
tool will collect and analyzes continuous physiologic data could provide early
clinical indicators of COVID-19 decompensation.
The National Cancer
Institute
Read More
Anthem, Apple Launches 2-Year Digital Asthma Study with Apple Watch
What You Should Know:
- Anthem, Inc. announced a new study that examines how
the use of everyday devices, like Apple Watch and iPhone, may help individuals
with asthma, led by the University of California, Irvine.
- Launching in the fall, the two-year, randomized controlled
study will enroll participants from Anthem-affiliated health plans who have
been clinically diagnosed with asthma.
-Anthem, Inc. today a new study that examines how the use of everyday devices, like Apple Watch
Read More
Analysis: August Health IT M&A Activity; Public Company Performance
– Healthcare Growth Partners’ (HGP) summary of Health IT/digital health mergers & acquisition (M&A) activity, and public company performance during the month of August 2020.
M&A is back and the velocity of the rebound has outpaced all expectations. The recovery quickly worked its way across the spectrum from large to small-cap, beginning with the larger cap NASDAQ rally of nearly 80% from lows in late March (only to soften in recent days), followed by multi-billion
Read More
Fitbit Launches Ready for Work Program to Help Employers Manage Workplace Health During COVID-19
What You Should Know:
- Fitbit launches new Ready for Work program to help
organizations with the unprecedented challenge of returning to the workplace
during the COVID-19 health crisis.
- The program combines key health biometrics from Fitbit devices along with symptom and temperature tracking into an easy-to-use daily check-in that provides employees with a recommendation on whether to go to work or stay home and seek medical care.
- Early research shows that resting heart rate data
Read More
Coronavirus Pandemic Reveals the Need for a Broader Digital Front Door
Healthcare facilities and providers around the country are experiencing COVID-19 differently. Many medical facilities treating COVID-19 patients have been overwhelmed, with some even resorting to creating pop-up hospitals to support the unexpected influx. Meanwhile, other providers have seen a sharp decline in their waiting rooms as patients have shied away from in-person appointments or had elective procedures postponed. Even patients with serious conditions are avoiding hospitals due to
Read More
Machine Learning Will Transform Medicine, but Only if We Use it Right
World chess champion Garry Kasparov made headlines all over the world in 1997 for something that he probably wasn’t very excited about. He lost a chess match. To a computer.
It was an IBM supercomputer called Deep Blue and its victory in that New York City match marked the first time a reigning world chess champion had been defeated by a computer under tournament conditions. It was also a symbolically significant event, the first sign that artificial intelligence could become equal to or even
Read More
Welkin Health Appoints Dr. Adrian Rawlinson Chief Medical Officer
What You Should Know:
- Wellkin Health appoints former him and hers executive Dr. Adrian Rawlinson as the company’s new Chief Medical Officer.
- In his new role as Chief Medical Officer. Dr. Rawlinson will focus on establishing a Clinical Advisory Board and Clinical User Group.
Welkin Health, a San Francisco-based digital health company, announced the appointment of Dr. Adrian Rawlinson to the company as Chief Medical Officer. In his role as Chief Medical Officer, Dr.
Read More
Executive Insights: Top Healthcare Predictions & Trends to Watch in 2020
As we close out the year, we asked several healthcare industry executives to share their predictions and trends for 2020.
Robbie Hughes, Founder, and CEO, Lumeon
“Following the announcement of the Trump administration's price transparency requirement – and the ensuing backlash from hospital groups – the issue of price transparency will dominate the healthcare industry next year. Regardless of the outcome of the lawsuit, I expect we'll see more attention around the importance of the
Read More
Philips, Paige Partner to Deliver Clinical Grade AI Apps to Pathology Laboratories
- Philips and Paige form a strategic partnership to deliver AI-based cancer assessment tools are poised to help pathologists improve speed and accuracy of cancer diagnostics, ultimately leading to better patient care. - Philips IntelliSite Pathology Solution in combination with Paige Prostate aims to provide an intuitive digital & computational pathology workflow experience. Philips plans to offer the CE-marked Paige Prostate to European pathology labs in 2020.Philips today announced a
Read More
